Images

Sources

Experiment + Assay

Phenotypes

Human Diseases

Fig. 3 B

Yamamoto T et al. (2023)

Xla Wt + hs6st1 CRISPR

NF15 (in situ hybridization)

Expression Phenotype
decreased amount sox3.L expression in neural plate

Fig. S3 ABCD

Yamamoto T et al. (2023)

Xla Wt + hs6st1 CRISPR

NF17-18 (in situ hybridization)

Expression Phenotype
decreased amount foxd3.L expression in cranial neural crest decreased amount krt12.4.L expression in neural plate decreased amount tfap2a.L expression in cranial neural crest

Fig. 3D

Yamamoto T et al. (2023)

Xla Wt + hs6st1 CRISPR

NF33/34 (in situ hybridization)

Expression Phenotype
decreased amount neurod1.L expression in eye decreased amount neurod1.L expression in retina decreased amount neurod1.L expression in retinal ganglion cell

Fig. 2 B r1, C; B r2, C

Yamamoto T et al. (2023)

Xla Wt + hs6st1.L

NF15 (in situ hybridization)

Expression Phenotype
decreased amount foxd3.L expression in cranial neural crest increased amount sox3.L expression in neural plate